Fiscal Period | 2023 |
---|---|
Period End Date | Mar 23 |
Revenue | 1217.97 |
Total Revenue | 1217.97 |
Costof Revenue Total | 246.07 |
Gross Profit | 971.90 |
Selling/ General/ Admin Expenses Total | 471.88 |
Depreciation/ Amortization | 60.35 |
Unusual Expense( Income) | 0.00 |
Other Operating Expenses Total | 156.22 |
Total Operating Expense | 934.52 |
Operating Income | 283.45 |
Interest Inc( Exp) Net- Non- Op Total | -195.30 |
Other Net | 36.76 |
Net Income Before Taxes | 300.68 |
Provisionfor Income Taxes | 49.76 |
Net Income After Taxes | 250.92 |
Net Income Before Extra Items | 250.92 |
Net Income | 250.92 |
Income Availableto Com Excl Extra Ord | 250.92 |
Income Availableto Com Incl Extra Ord | 250.92 |
Diluted Net Income | 250.92 |
Diluted Weighted Average Shares | 97.70 |
Diluted EPS Excluding Extra Ord Items | 2.57 |
DPS- Common Stock Primary Issue | 1.00 |
Diluted Normalized EPS | 2.57 |
Max Healthcare Institute Dividend | Max Healthcare Institute Bonus | Max Healthcare Institute News | Max Healthcare Institute AGM | Max Healthcare Institute Rights | Max Healthcare Institute Splits | Max Healthcare Institute Board Meetings | Max Healthcare Institute Key Metrics | Max Healthcare Institute Shareholdings | Max Healthcare Institute Profit Loss | Max Healthcare Institute Balance Sheet | Max Healthcare Institute Cashflow | Max Healthcare Institute Q1 Results | Max Healthcare Institute Q2 Results | Max Healthcare Institute Q3 Results
Top Gainers | Top Losers | Indian Indices | BSE Active Stocks | NSE Active Stocks